HOME >> MEDICINE >> NEWS
Airport screening unlikely to prevent spread of SARS or influenza

Screening passengers as they arrive at UK airports is unlikely to prevent the importation of either SARS or influenza, finds a study published online by the BMJ today.

In the event of a new SARS or influenza epidemic, air travel would represent the principal route of international spread. Although airport entry screening has been advocated, its benefit is currently unknown.

Using the incubation periods for influenza and SARS, researchers at the Health Protection Agency estimated the proportion of passengers with latent infection who would develop symptoms during any flight to the UK.

For SARS, they found that the incubation period was too long to allow more than a small proportion of infected individuals to develop symptoms during a flight to the UK (0-3% for European flights and a maximum of 21% for the longest flights from East Asia).

Although influenza has a much shorter incubation period than SARS, the average predicted proportion of people infected with influenza and progressing during any flight was still less than 10%.

Because the proportion of individuals detected is highest from cities with the longest flight duration, screening passengers from the Far East and Australasia derives the most benefit. But, even then, the sensitivity for cities in these areas would still be low, explain the authors.

Early screening is unlikely to be effective in preventing the importation of either SARS or influenza, they conclude.

Although adopting a policy of quarantining all exposed passengers on the detection of a single case could substantially increase the benefit of entry screening, this still leaves the problem that the sensitivity of entry screening is low.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
22-Sep-2005


Page: 1

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Osteoporosis screening and treatment may be cost-effective for selected older men
3. Syphilis screening, lithium fights neurodegeneration, monoclonal antibodies against avian flu
4. Advances in screening and markers improve early detection of colorectal cancer
5. GI screening: Racing time or wasting time?
6. Routine HIV screening in the ED is cost effective and well liked by patients
7. Simple screening can help decrease teen risk behaviors
8. Johns Hopkins begins aggressive screening for superbugs in children
9. Study recommends universal newborn screening for cystic fibrosis
10. Opportunistic chlamydia screening not underpinned by sound evidence
11. New guideline for screening mammography for women 40 to 49 years of age

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Airport screening unlikely prevent spread SARS influenza

(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Association Annual Conference to be held April 10-11, ... Columbus, OH. , The OPTA Annual Conference ... products and services. , Representatives from Aureus ...
(Date:3/28/2015)... Designers and Professionals of FCPX ... 5K from Pixel Film Studios. , “Scratches 5K allows ... inside Final Cut Pro X” Said Christina Austin, CEO ... is an effective tool for any FCPX editor.” , ... intuitive grunge overlays. Simply drag title layers into the ...
(Date:3/28/2015)... CA (PRWEB) March 28, 2015 ... specialists , this week released a report about the ... symptoms of asthma sufferers, and according to recent medical ... , According to the Environmental Protection Agency, people ... asthmatic reactions. Breathing in mold may trigger asthma attacks ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Wellness for ... and business criteria for the spa and wellness industry–has ... clients who have experienced or are living with cancer. ... Spafinder Wellness 365® Network, will be identified with a ... as a provider of safe, therapeutic services for cancer ...
(Date:3/27/2015)... York (PRWEB) March 27, 2015 The ... ) that allege the statin medication increases the risk ... granted Pfizer Inc.’s Motion to Dismiss four individual cases ... a Case Management Order issued in the U.S. District ... Court determined that the dismissals were warranted because the ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
(Date:3/27/2015)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... announced registered offering of common shares in ... the Offering, the Company issued 7,286,432 common shares at ... proceeds of approximately $1.45 billion. On March 18, 2015, ... Commission a final prospectus supplement to its effective shelf ...
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
Cached News: